Denosumab improves bone mineral density, promotes fracture healing, and reduces recurrent fractures in patients with osteoporotic fractures
Denosumab substantially enhanced BMD, accelerated fracture healing, reduced recurrent fracture risk, and alleviated pain in patients with osteoporotic fracture, with a safety profile comparable to zoledronic acid.
Authors
- Shangdong Liang (ORCID: https://orcid.org/0000-0003-0903-3004)
Institutions
- Yan'an University (CN)
Publication Details
- Journal
- American Journal of Translational Research
- Published
- 2025-01-01
- DOI
- https://doi.org/10.62347/sdnl9227
- Primary Topic
- Bone health and osteoporosis research
- Type
- article
- Field-Weighted Citation Impact
- 0.00